Live: Arista Networks Is Reporting Q1 Earnings. Can $ANET Continue Its 32% YTD Rally?

Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Mar 6, 2017 at 9:50 AM EST

Where Merck and Pfizer’s Type 2 Diabetes Treatment Can Go From Here

Merck and Pfizer each saw their shares sink early on Monday after the firms gave an update on their type…

Chris Lange | Mar 4, 2017 at 9:45 AM EST

Why Analysts Are Looking at Valeant Pharma Differently After Earnings

Valeant Pharmaceuticals shares hit a multiyear low this past week, and some analysts took this opportunity to reevaluate their stance…

Lee Jackson | Mar 3, 2017 at 9:55 AM EST

Wedbush Has 3 Biotech Stocks to Buy With Massive Upside Potential

Here are three biotech companies that not only have data that could prove to be huge, but their shares have…

Chris Lange | Mar 2, 2017 at 12:20 PM EST

Thursday’s Top Biopharma Movers

Opko Health and a few other biopharma companies made massive runs on Thursday.

Lee Jackson | Mar 2, 2017 at 8:25 AM EST

RBC Says These Top Health Care Stocks Could Be 2017 Takeover Candidates

Each year, the analysts at RBC come out with a detailed list of smaller companies they feel are targets for…

Chris Lange | Mar 1, 2017 at 11:35 AM EST

4 Biopharma Stocks Moving the Market on Wednesday

These are some of the biggest biopharma stocks moving on Wednesday, as markets have hit new intraday highs, continuing to…

Chris Lange | Feb 28, 2017 at 12:05 PM EST

Why Valeant Missed the Mark Despite an Earnings Beat

Valeant Pharmaceuticals reported better-than-expected fourth-quarter financial results before the markets opened on Tuesday.

Chris Lange | Feb 28, 2017 at 10:15 AM EST

Short Sellers Hike Their Bets in Major Biotechs

The February 15 short interest data have been compared with the previous report, and short interest increased in all the…

Chris Lange | Feb 28, 2017 at 8:55 AM EST

Why Short Sellers Are Making a Massive Bet in Major Pharma

Judging by this report, short sellers are making a tremendous bet against Trump’s plan to reform the health care sector.

Chris Lange | Feb 27, 2017 at 12:10 PM EST

How La Jolla’s Low Blood Pressure Treatment Is Driving New Highs

La Jolla Pharmaceutical saw its shares skyrocket on Monday after top-line results from its late-stage study of patients with catecholamine…

Chris Lange | Feb 25, 2017 at 10:25 AM EST

Top Biopharma Movers of the Past Week

The health care sector was in trouble over the past year, under fire from congressional hearings and politicians on the…

Jon C. Ogg | Feb 24, 2017 at 1:45 PM EST

Is There More Than Meets the Eye on Celgene’s President, COO Retirement?

Celgene shares were trading lower on Friday due to a key management retirement. The problem is that this retirement is…

Chris Lange | Feb 24, 2017 at 11:35 AM EST

Is This the Turnaround Cempra Has Been Looking For?

Shares of Cempra saw an incredible gain on Friday after the company announced the results from its late-stage trial for…

Lee Jackson | Feb 23, 2017 at 8:15 AM EST

Large Cap Biotech Stocks to Buy May Be the Cheapest in Years

One area is dirt cheap now, and in some cases pays dividends and has big growth prospects, and that is…

Jon C. Ogg | Feb 22, 2017 at 11:25 AM EST

With New Cash and Cancer Targets, Analyst Sees Almost 200% Upside in Sierra Oncology

After a fresh capital raise of about $26 million, at least one analyst is calling for Sierra Oncology stock to…

1 … 172 173 174 175 176 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Where Merck and Pfizer’s Type 2 Diabetes Treatment Can Go From Here

Why Analysts Are Looking at Valeant Pharma Differently After Earnings

Wedbush Has 3 Biotech Stocks to Buy With Massive Upside Potential

Thursday’s Top Biopharma Movers

RBC Says These Top Health Care Stocks Could Be 2017 Takeover Candidates

4 Biopharma Stocks Moving the Market on Wednesday

Why Valeant Missed the Mark Despite an Earnings Beat

Short Sellers Hike Their Bets in Major Biotechs

Why Short Sellers Are Making a Massive Bet in Major Pharma

How La Jolla’s Low Blood Pressure Treatment Is Driving New Highs

Top Biopharma Movers of the Past Week

Is There More Than Meets the Eye on Celgene’s President, COO Retirement?

Is This the Turnaround Cempra Has Been Looking For?

Large Cap Biotech Stocks to Buy May Be the Cheapest in Years

With New Cash and Cancer Targets, Analyst Sees Almost 200% Upside in Sierra Oncology

Live: Arista Networks Is Reporting Q1 Earnings. Can $ANET Continue Its 32% YTD Rally?

Live: AMD Reports Q1 Earnings Tonight. Will the Stock Continue Its 255% 1-Year Explosion?

Live: Supermicro Reports Q3 Earnings Tonight. Can Strong Results Spark a Rebound?

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

Jim Cramer Isn’t a Fan of Microsoft After Rough Quarter. Is He Right to Be Skeptical?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

27% of Americans Own ETFs but Allocate Just 6%, Here's Why That Costs Them Retirement Income

Live: Navitas Semiconductor Q1 Earnings Tonight. Can the 676% Surge Survive the Print?

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

Health and Healthcare Articles

All Health and Healthcare Articles

Where Merck and Pfizer’s Type 2 Diabetes Treatment Can Go From Here

Why Analysts Are Looking at Valeant Pharma Differently After Earnings

Wedbush Has 3 Biotech Stocks to Buy With Massive Upside Potential

Thursday’s Top Biopharma Movers

RBC Says These Top Health Care Stocks Could Be 2017 Takeover Candidates

4 Biopharma Stocks Moving the Market on Wednesday

Why Valeant Missed the Mark Despite an Earnings Beat

Short Sellers Hike Their Bets in Major Biotechs

Why Short Sellers Are Making a Massive Bet in Major Pharma

How La Jolla’s Low Blood Pressure Treatment Is Driving New Highs

Top Biopharma Movers of the Past Week

Is There More Than Meets the Eye on Celgene’s President, COO Retirement?

Is This the Turnaround Cempra Has Been Looking For?

Large Cap Biotech Stocks to Buy May Be the Cheapest in Years

With New Cash and Cancer Targets, Analyst Sees Almost 200% Upside in Sierra Oncology

Live: Arista Networks Is Reporting Q1 Earnings. Can $ANET Continue Its 32% YTD Rally?

Live: AMD Reports Q1 Earnings Tonight. Will the Stock Continue Its 255% 1-Year Explosion?

Live: Supermicro Reports Q3 Earnings Tonight. Can Strong Results Spark a Rebound?

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

Jim Cramer Isn’t a Fan of Microsoft After Rough Quarter. Is He Right to Be Skeptical?

Featured Reads

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

27% of Americans Own ETFs but Allocate Just 6%, Here's Why That Costs Them Retirement Income